These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 25838146

  • 21. Design, synthesis and biological evaluation of hetero-aromatic moieties substituted pyrrole-2-carbonitrile derivatives as dipeptidyl peptidase IV inhibitors.
    Ji X, Su M, Wang J, Deng G, Deng S, Li Z, Tang C, Li J, Li J, Zhao L, Jiang H, Liu H.
    Eur J Med Chem; 2014 Mar 21; 75():111-22. PubMed ID: 24531224
    [Abstract] [Full Text] [Related]

  • 22. Benzo[4,5]thieno[2,3-d]pyrimidine phthalimide derivative, one of the rare noncompetitive inhibitors of dipeptidyl peptidase-4.
    Tomovic K, Ilic BS, Miljkovic M, Dimov S, Yancheva D, Kojic M, Mavrova AT, Kocic G, Smelcerovic A.
    Arch Pharm (Weinheim); 2020 Jan 21; 353(1):e1900238. PubMed ID: 31710123
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Discovery and Rational Design of Natural-Product-Derived 2-Phenyl-3,4-dihydro-2H-benzo[f]chromen-3-amine Analogs as Novel and Potent Dipeptidyl Peptidase 4 (DPP-4) Inhibitors for the Treatment of Type 2 Diabetes.
    Li S, Xu H, Cui S, Wu F, Zhang Y, Su M, Gong Y, Qiu S, Jiao Q, Qin C, Shan J, Zhang M, Wang J, Yin Q, Xu M, Liu X, Wang R, Zhu L, Li J, Xu Y, Jiang H, Zhao Z, Li J, Li H.
    J Med Chem; 2016 Jul 28; 59(14):6772-90. PubMed ID: 27396490
    [Abstract] [Full Text] [Related]

  • 26. Synthesis and biological evaluation of all eight stereoisomers of DPP-IV inhibitor saxagliptin.
    Dong J, Gong Y, Liu J, Chen X, Wen X, Sun H.
    Bioorg Med Chem; 2014 Feb 15; 22(4):1383-93. PubMed ID: 24457090
    [Abstract] [Full Text] [Related]

  • 27. Design, synthesis and biological evaluation of glycolamide, glycinamide, and β-amino carbonyl 1,2,4-triazole derivatives as DPP-4 inhibitors.
    Fuh MT, Tseng CC, Li SM, Tsai SE, Chuang TJ, Lu CH, Yang YC, Tsai HJ, Wong FF.
    Bioorg Chem; 2021 Sep 15; 114():105049. PubMed ID: 34147879
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Structure based virtual screening of MDPI database: discovery of structurally diverse and novel DPP-IV inhibitors.
    Tanwar O, Tanwar L, Shaquiquzzaman M, Alam MM, Akhter M.
    Bioorg Med Chem Lett; 2014 Aug 01; 24(15):3447-51. PubMed ID: 24948564
    [Abstract] [Full Text] [Related]

  • 30. Synthesis and biological evaluation of xanthine derivatives on dipeptidyl peptidase 4.
    Lin K, Cai Z, Wang F, Zhang W, Zhou W.
    Chem Pharm Bull (Tokyo); 2013 Aug 01; 61(4):477-82. PubMed ID: 23358258
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Synthesis, evaluation and molecular docking of prolyl-fluoropyrrolidine derivatives as dipeptidyl peptidase IV inhibitors.
    Sharma M, Gupta M, Singh D, Kumar M, Kaur P.
    Chem Biol Drug Des; 2013 Aug 01; 82(2):156-66. PubMed ID: 23581745
    [Abstract] [Full Text] [Related]

  • 35. Design and synthesis of aminocoumarin derivatives as DPP-IV inhibitors and anticancer agents.
    Soni R, Soman SS.
    Bioorg Chem; 2018 Sep 01; 79():277-284. PubMed ID: 29783098
    [Abstract] [Full Text] [Related]

  • 36. Optimization of the benzamide fragment targeting the S2' site leads to potent dipeptidyl peptidase-IV inhibitors.
    Deng X, Wang N, Meng L, Zhou S, Huang J, Xing J, He L, Jiang W, Li Q.
    Bioorg Chem; 2020 Jan 01; 94():103366. PubMed ID: 31640932
    [Abstract] [Full Text] [Related]

  • 37. Dipeptidyl peptidase IV and its inhibitors: therapeutics for type 2 diabetes and what else?
    Juillerat-Jeanneret L.
    J Med Chem; 2014 Mar 27; 57(6):2197-212. PubMed ID: 24099035
    [Abstract] [Full Text] [Related]

  • 38. The highly potent and selective dipeptidyl peptidase IV inhibitors bearing a thienopyrimidine scaffold effectively treat type 2 diabetes.
    Deng J, Peng L, Zhang G, Lan X, Li C, Chen F, Zhou Y, Lin Z, Chen L, Dai R, Xu H, Yang L, Zhang X, Hu W.
    Eur J Med Chem; 2011 Jan 27; 46(1):71-6. PubMed ID: 21106276
    [Abstract] [Full Text] [Related]

  • 39. Synthesis, structure-activity relationship, and pharmacophore modeling studies of pyrazole-3-carbohydrazone derivatives as dipeptidyl peptidase IV inhibitors.
    Wu D, Jin F, Lu W, Zhu J, Li C, Wang W, Tang Y, Jiang H, Huang J, Liu G, Li J.
    Chem Biol Drug Des; 2012 Jun 27; 79(6):897-906. PubMed ID: 22381062
    [Abstract] [Full Text] [Related]

  • 40. Discovery of new chemotype dipeptidyl peptidase IV inhibitors having (R)-3-amino-3-methyl piperidine as a pharmacophore.
    Nishio Y, Kimura H, Tosaki S, Sugaru E, Sakai M, Horiguchi M, Masui Y, Ono M, Nakagawa T, Nakahira H.
    Bioorg Med Chem Lett; 2010 Dec 15; 20(24):7246-9. PubMed ID: 21074430
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.